Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents
/in Cervical Cancer, Hyperthermia, International Publications /von 2018-08-16 / Int J Mol Sci 2018 Aug;19(8)Hyperthermia in cervical cancer – current status
/in Cervical Cancer, Hyperthermia, International Publications /von 2018-06-15 / Rep Pract Oncol Radiother 2018 Nov-Dec;23(6):595-603Poly(I:C) enhanced anti-cervical cancer immunities induced by dendritic cells-derived exosomes
/in Cervical Cancer, Dendritic Cells, Exosome, International Publications /von 2018-02-08 / Int. J. Biol. Macromol. 2018 Jul;113:1182-1187The effect of modulated electro-hyperthermia on temperature and blood flow in human cervical carcinoma
/in Cervical Cancer, Hyperthermia, International Publications /von 2018-01-21 / Int J Hyperthermia 2018 11;34(7):953-960Treatment outcome analysis of chemotherapy combined with modulated electro-hyperthermia compared with chemotherapy alone for recurrent cervical cancer, following irradiation
/in Cervical Cancer, Hyperthermia, International Publications /von 2017-05-04 / Oncol Lett 2017 Jul;14(1):73-78A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer
/in Cervical Cancer, Hyperthermia, International Publications /von 2017-04-27 / Radiat Oncol 2017 Apr;12(1):75Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses
/in Cervical Cancer, Hyperthermia, International Publications /von 2016-08-14 / Int J Hyperthermia 2016 11;32(7):809-21A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer
/in Cervical Cancer, Hyperthermia, International Publications /von 2016-08-12 / Int J Hyperthermia 2016 11;32(7):801-8Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
/in Cervical Cancer, Dendritic Cells, International Publications /von 2016-05-31 / J Gynecol Oncol 2016 Sep;27(5):e51
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de